Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API

RGEN
Repligen Corp
stock NASDAQ

At Close
Apr 9, 2026 3:59:57 PM EDT
119.79USD+0.013%(+0.02)609,718
0.00Bid   0.00Ask   0.00Spread
Pre-market
0.00USD-100.000%(-119.77)0
After-hours
Apr 9, 2026 4:00:30 PM EDT
119.78USD-0.004%(-0.01)16,963
OverviewOption ChainMax PainOptionsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsMore
open chart   
open chart   
Market Cap
6.76B
Headquarters
Waltham, Massachusetts, USA
Industry
Medical Instruments & Supplies
Next Earnings
May 5, 2026 (25d)
Related
NVAXNBIXBMRNSGMOBMYGEPFETMOCRLCLBSXLV
RGEN Stats
Avg. Vol. 10 Day
891,314
Avg. Vol. 30 Day
894,845
Employees
476
Market Cap
6,761,144,967
Shares Out.
56,399,274
On/Off Exchange
58%/42%
6 Month Beta
1.51
1 Year Beta
1.56
2 Year Beta
1.42
3 Year Beta
1.43
52 Week Low
105.06
52 Week High
175.77
SMA50
129.06
SMA200
138.24
1 Week
+1.78%
1 Month
-6.26%
3 Month
-28.14%
6 Month
-19.44%
1 Year
-3.21%
2 Year
-34.10%
5 Year
-41.83%
Profile
repligen corporation is a life sciences company focused on the development, production and commercialization of products used in the process of manufacturing biological drugs. our bioprocessing products are sold to major life sciences and biopharmaceutical companies worldwide. we are a leading manufacturer of protein a, a critical reagent used to manufacture monoclonal antibody-based therapeutics. we also supply several growth factor products used to increase cell culture productivity in biomanufacturing. in the burgeoning area of disposable biomanufacturing technologies, we have developed and market a series of opusâ„¢ (open platform user specified) single-use chromatography columns used in the biologics purification process. repligen's corporate headquarters are located in waltham, ma, usa; we have an additional manufacturing facility in lund, sweden.

RGEN Stock Summary

Repligen Corp (NASDAQ:RGEN) stock price today is $119.79, and today's volume is 609,718. RGEN is up 0.013% today. The 30 day average volume is 894,845. RGEN market cap is 6.76B with 56,399,274 shares outstanding.



Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC